Does ionizing radiation influence Alzheimer's disease risk?

Journal of Radiation Research

Volumn 53, Issue 6, 2012, Pages 815-822

  Begum, Nasrin ^a,b   Wang, Bing ^b   Mori, Masahiko ^b   Vares, Guillaume ^a,b  

^a RAJSHAHI MEDICAL COLLEGE   (Bangladesh)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

aging; Alzheimer's disease; cognitive effects; dementia; ionizing radiation

Indexed keywords

IONIZING RADIATION; RADIATION EFFECTS; RADIATION SHIELDING;

AGE-RELATED; ALZHEIMERS DISEASE; BIOLOGICAL EFFECTS; COGNITIVE EFFECTS; DISEASE RISKS; IONIZING RADIATION; RADIATION DISEASE;

NEURODEGENERATIVE DISEASES;

EID: 84870011570     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs036     Document Type: Review

References (120)

1. Wang X, Su B, Perry G et al. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Free Radic Biol Med 2007;43:1569-73. (Pubitemid 350122990)
2. Hampel H, Prvulovic D, Teipel S et al. The future of Alzheimer's disease: the next 10 years. Prog Neurobiol 2011;95:718-28.
3. Hebert LE, Scherr PA, Bienias JL et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-22. (Pubitemid 36975801)
4. Philipson O, Lord A, Gumucio A et al. Animal models of amyloid-beta-related pathologies in Alzheimer's disease. FEBS J 2010;277:1389-409.
5. Chandana SR, Movva S, Arora M et al. Primary brain tumors in adults. Am Fam Physician 2008;77:1423-30.
6. Elaimy AL, Mackay AR, Lamoreaux WT et al. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors. World Neurosurg 2011;75:673-83.
7. Asai A, Matsutani M, Kohno T et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 1989;63:1962-74. (Pubitemid 19118897)
8. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 1990;28:818-22.
9. Lowe XR, Bhattacharya S, Marchetti F et al. Early brain response to low-dose radiation exposure involves molecular networks and pathways associated with cognitive functions, advanced aging and Alzheimer's disease. Radiat Res 2009;171:53-65.
10. Cacabelos R. Pharmacogenomics and therapeutic prospects in dementia. Eur Arch Psychiatry Clin Neurosci 2008;258 (Suppl 1):28-47. (Pubitemid 351424036)
11. Demarin V, Zavoreo I, Kes VB et al. Biomarkers in Alzheimer's disease. Clin Chem Lab Med 2011;49:773-8.
12. Schaeffer EL, Figueiro M, Gattaz WF. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo) 2011;66(Suppl 1):45-54.
13. Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-92.
14. Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease - a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2012;2:a006346.
15. Nunomura A, Perry G, Aliev G et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759-67. (Pubitemid 32678256)
16. Smith MA, Hirai K, Hsiao K et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998;70:2212-15. (Pubitemid 28207848)
17. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011;70:532-40.
18. Calissano P, Matrone C, Amadoro G. Apoptosis and in vitro Alzheimer disease neuronal models. Commun Integr Biol 2009;2:163-9.
19. Patrias LM, Klaver AC, Coffey MP et al. Effects of external beam radiation on in vitro formation of Abeta1-42 fibrils and preformed fibrils. Radiat Res 2011;175:375-81.
20. Frautschy SA, Baird A, Cole GM Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci USA 1991;88:8362-6. (Pubitemid 21915356)
21. Valko M, Leibfritz D, Moncol J et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. (Pubitemid 44566469)
22. Hirai K, Aliev G, Nunomura A et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001;21:3017-23. (Pubitemid 32323483)
23. Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 2007;64:954-6. (Pubitemid 47047994)
24. Nunomura A, Hofer T, Moreira PI et al. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 2009;118:151-66.
25. Nunomura A, Perry G, Aliev G et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759-67. (Pubitemid 32678256)
26. Dalle-Donne I, Rossi R, Colombo R et al. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-23.
27. Mancuso C, Bates TE, Butterfield DA et al. Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs 2007;16:1921-31. (Pubitemid 351403724)
28. Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-23. (Pubitemid 28467033)
29. Manczak M, Park BS, Jung Y et al. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 2004;5:147-62. (Pubitemid 38596548)
30. Reddy PH and Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 2005;49:618-32. (Pubitemid 41546661)
31. Varadarajan S, Yatin S, Aksenova M et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 2000;130:184-208.
32. Abramov AY, Canevari L, Duchen MR. Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 2004;1742:81-7. (Pubitemid 39601768)
33. Maurer I, Zierz S, Möller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000;21:455-62. (Pubitemid 30349116)
34. Berndt JD, Callaway NL, Gonzalez-Lima F. Effects of chronic sodium azide on brain and muscle cytochrome oxidase activity: a potential model to investigate environmental contributions to neurodegenerative diseases. J Toxicol Environ Health A 2001;63:67-77. (Pubitemid 32391857)
35. Bertram L, McQueen MB, Mullin K et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23. (Pubitemid 46026496)
36. Hollingworth P, Harold D, Sims R et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011;43:429-35.
37. Naj AC, Jun G, Beecham GW et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011;43:436-41.
38. Lambert J-C, Heath S, Even G et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-99.
39. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009;10:333-44.
40. Jones L, Holmans PA, Hamshere ML et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010;5:e13950.
41. Belka C, Budach W, Kortmann RD et al. Radiation induced CNS toxicity - molecular and cellular mechanisms. Br J Cancer 2001;85:1233-9. (Pubitemid 33081913)
42. Schultheiss TE, Kun LE, Ang KK et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995;31:1093-112.
43. Abayomi OK. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol 1996;35:659-63. (Pubitemid 26366721)
44. Mizumatsu S, Monje ML, Morhardt DR et al. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 2003;63:4021-7. (Pubitemid 36917922)
45. Raber J. Unintended effects of cranial irradiation on cognitive function. Toxicol Pathol 2010;38:198-202.
46. Raber J, Villasana L, Rosenberg J et al. Irradiation enhances hippocampus-dependent cognition in mice deficient in extracellular superoxide dismutase. Hippocampus 2011;21: 72-80.
47. Maire JP, Coudin B, Guérin J et al. Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol 1987;10:156-62. (Pubitemid 17055333)
48. Suzuki Y, Tanaka R, Miyakawa T et al. Evaluation of radiation therapy for metastatic brain tumor by computed tomography. Neurol Med Chir (Tokyo) 1985;25:837-43. (Pubitemid 16257669)
49. Lowe XR, Marchetti F, Lu X et al. Molecular stress response in the CNS of mice after systemic exposure to interferon-alpha, ionizing radiation and ketamine. Neurotoxicology 2009;30:261-8.
50. Schull WJ, Otake M. Cognitive function and prenatal exposure to ionizing radiation. Teratology 1999;59:222-6. (Pubitemid 29231838)
51. Monje ML, Mizumatsu S, Fike JR et al. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002;8:955-62. (Pubitemid 35033699)
52. Rola R, Raber J, Rizk A et al. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol 2004;188:316-30. (Pubitemid 38891593)
53. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003;302:1760-5. (Pubitemid 37505739)
54. Ben Abdallah NM-B, Slomianka L, Lipp H-P. Reversible effect of X-irradiation on proliferation, neurogenesis, and cell death in the dentate gyrus of adult mice. Hippocampus 2007;17:1230-40. (Pubitemid 350244238)
55. Arvidsson A, Kokaia Z, Airaksinen MS et al. Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain. Neuroscience 2001;106:27-41. (Pubitemid 32831071)
56. Liu J, Solway K, Messing RO et al. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 1998;18:7768-78. (Pubitemid 28441018)
57. van Praag H, Schinder AF, Christie BR et al. Functional neurogenesis in the adult hippocampus. Nature 2002;415:1030-4. (Pubitemid 34193451)
58. Raber J, Rola R, LeFevour A et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res 2004;162:39-47. (Pubitemid 39044717)
59. Shors TJ, Townsend DA, Zhao M et al. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 2002;12:578-84.
60. Zhu C, Huang Z, Gao J et al. Irradiation to the immature brain attenuates neurogenesis and exacerbates subsequent hypoxic-ischemic brain injury in the adult. J Neurochem 2009;111:1447-56.
61. Li Y-Q, Chen P, Haimovitz-Friedman A et al. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res 2003;63:5950-6. (Pubitemid 37187496)
62. Ljubimova NV, Levitman MK, Plotnikova ED et al. Endothelial cell population dynamics in rat brain after local irradiation. Br J Radiol 1991;64:934-40.
63. Peña LA, Fuks Z, Kolesnick RN. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 2000;60:321-7. (Pubitemid 30070758)
64. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011;37:56-74.
65. Herzog KH, Chong MJ, Kapsetaki M et al. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998;280:1089-91. (Pubitemid 28234952)
66. Chong MJ, Murray MR, Gosink EC et al. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc Natl Acad Sci USA 2000;97:889-94. (Pubitemid 30070405)
67. Hallahan DE, Spriggs DR, Beckett MA et al. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 1989;86:10104-7. (Pubitemid 20030785)
68. Cammer W. Effects of TNFα on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000;864:213-19. (Pubitemid 30235103)
69. Quarmby S, Kumar P, Kumar S. Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte- endothelial cell interactions. Int J Cancer 1999;82: 385-95. (Pubitemid 29302980)
70. Amundson SA. Functional genomics in radiation biology: a gateway to cellular systems-level studies. Radiat Environ Biophys 2008;47:25-31.
71. Kalanxhi E, Dahle J. Genome-wide microarray analysis of human fibroblasts in response to γ radiation and the radiation-induced bystander effect. Radiat Res 2012;177:35-43.
72. Roy L, Gruel G, Vaurijoux A. Cell response to ionising radiation analysed by gene expression patterns. Ann Ist Super Sanita 2009;45:272-7.
73. Vares G, Wang B, Shang Y et al. Adaptive response in embryogenesis: vi. Comparative microarray analysis of gene expressions in mouse fetuses. Int J Radiat Biol 2009;85:70-86.
74. Yin E, Nelson DO, Coleman MA et al. Gene expression changes in mouse brain after exposure to low-dose ionizing radiation. Int J Radiat Biol 2003;79:759-75. (Pubitemid 37468143)
75. Richardson RB. Ionizing radiation and aging: rejuvenating an old idea. Aging (Albany NY) 2009;1:887-902.
76. Cardis E, Gilbert ES, Carpenter L et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 1995;142:117-32.
77. Preston DL, Shimizu Y, Pierce DA et al. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003;160:381-407. (Pubitemid 37174507)
78. Neriishi K, Nakashima E, Minamoto A et al. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiat Res 2007;168:404-8. (Pubitemid 351303167)
79. Hamilton SA, Pecaut MJ, Gridley DS et al. A murine model for bone loss from therapeutic and space-relevant sources of radiation. J Appl Physiol 2006;101:789-93. (Pubitemid 44352290)
80. Anderson RE. Longevity in radiated human populations, with particular reference to the atomic bomb survivors. Am J Med 1973;55:643-56.
81. Becker N, Liebermann D, Wesch H et al. Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study. Eur J Cancer 2008;44:1259-68.
82. Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999;222:236-45. (Pubitemid 129708638)
83. Lu CY, Lee HC, Fahn HJ et al. Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin. Mutat Res 1999;423:11-21.
84. Mecocci P, Fanó G, Fulle S et al. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic Biol Med 1999;26:303-8. (Pubitemid 29013460)
85. Mutlu-Türkolu U, Ilhan E, Oztezcan S et al. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 2003;36:397-400. (Pubitemid 36776810)
86. Stadtman ERProtein oxidation and aging. Free Radic Res 2006;40:1250-8.
87. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345: 458-60.
88. Hastie ND, Dempster M, Dunlop MG et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-8.
89. Lindsey J, McGill NI, Lindsey LA et al. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;256:45-8.
90. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426:194-8.
91. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003; 13:1549-56. (Pubitemid 37078413)
92. Henle ES, Han Z, Tang N et al. Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J Biol Chem 1999;274:962-71.
93. Kharbanda S, Kumar V, Dhar S et al. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr Biol 2000;10:568-75. (Pubitemid 30329441)
94. Derradji H, Bekaert S, De Meyer T et al. Ionizing radiation-induced gene modulations, cytokine content changes and telomere shortening in mouse fetuses exhibiting forelimb defects. Dev Biol 2008;322:302-13.
95. Little MP. Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model? Mutat Res 2010;687:17-27.
96. García AM, Sisternas A, Hoyos SP. Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. Int J Epidemiol 2008;37:329-40. (Pubitemid 351494210)
97. Little MP. Cancer and non-cancer effects in Japanese atomic bomb survivors. J Radiol Prot 2009;29:A43-A59.
98. Yamada M, Sasaki H, Mimori Y et al. Prevalence and risks of dementia in the Japanese population: RERF's adult health study Hiroshima subjects. Radiation Effects Research Foundation. J Am Geriatr Soc 1999;47:189-95. (Pubitemid 29082719)
99. Vlkolinsky R, Titova E, Krucker T et al. Exposure to 56Fe-particle radiation accelerates electrophysiological alterations in the hippocampus of APP23 transgenic mice. Radiat Res 2010;173:342-52.
100. Waldau B, Shetty AK. Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci 2008;65:2372-84.
101. Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: focus on the telomere. Neuroscience 2007;145:1439-48. (Pubitemid 46602741)
102. von Zglinicki T, Saretzki G, Döcke W et al. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995;220:186-93.
103. Zhang J, Kong Q, Zhang Z et al. Telomere dysfunction of lymphocytes in patients with Alzheimer disease. Cogn Behav Neurol 2003;16:170-6. (Pubitemid 37243440)
104. Honig LS, Schupf N, Lee JH et al. Shorter telomeres are associated with mortality in those with APOE 4 and dementia. Ann Neurol 2006;60:181-7. (Pubitemid 44182393)
105. Panossian LA, Porter VR, Valenzuela HF et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003;24:77-84. (Pubitemid 35454145)
106. Ming G-L, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005;28:223-50. (Pubitemid 41098905)
107. Rolyan H, Scheffold A, Heinrich A et al. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice. Brain 2011;134:2044-56.
108. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 2009;66:300-5.
109. Arvanitakis Z, Wilson RS, Bienias JL et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661-6. (Pubitemid 38637681)
110. Yaffe K, Fiocco AJ, Lindquist K et al. Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology 2009;72:2029-35.
111. Moulton PV, Yang W. Air pollution, oxidative stress, and Alzheimer's disease. J Environ Public Health 2012;2012:472751.
112. Delfino RJ, Staimer N, Vaziri ND. Air pollution and circulating biomarkers of oxidative stress. Air Quality, Atmosphere & Health 2011;4:37-52.
113. Calderón-Garcidueñas L, Kavanaugh M, Block M et al. Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults. J Alzheimers Dis 2012;28:93-107.
114. Yang H, Jin X, Kei Lam CW et al. Oxidative stress and diabetes mellitus. Clin Chem Lab Med 2011;49:1773-82.
115. Hampel H, Prvulovic D, Teipel S et al. The future of Alzheimer's disease: the next 10 years. Prog Neurobiol 2011;95:718-28.
116. Klokov D, Criswell T, Leskov KS et al. IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects. Mutat Res 2004;568:97-110. (Pubitemid 39458300)
117. Trougakos IP, Gonos ES. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic Res 2006;40:1324-34. (Pubitemid 44698281)
118. Rosenberg ME, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;27:633-45.
119. Calero M, Rostagno A, Matsubara E et al. Apolipoprotein (J clusterin) and Alzheimer's disease. Microsc Res Tech 2000;50:305-15.
120. Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-92.